7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Anixa Biosciences, Inc
(NASDAQ:ANIX) 

ANIX stock logo

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen rec...

Founded: 1982
Full Time Employees: 7
Sector: Healthcare
Industry: Diagnostics & Research

Share this website to your friends
Anixa Biosciences Days Payable Outstanding ttm (DPO)
202110 202111 202112 202201 202202 202203 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 096.35192.69289.04385.38481.73578.07674.42
Anixa Biosciences Days Receivable Outstanding ttm (DSO)
202110 202111 202112 202201 202202 202203 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 067.04134.08201.12268.16335.2402.24469.29
Anixa Biosciences Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -0.24-0.2-0.17-0.13-0.1-0.07-0.030
Anixa Biosciences Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -0.24-0.2-0.17-0.13-0.1-0.07-0.030
Anixa Biosciences Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.150.310.460.610.760.921.07
Anixa Biosciences P/S ratio ttm
202110 202111 202112 202201 202202 202203 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 099.2198.39297.59396.79495.98595.18694.37
Anixa Biosciences (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -15.23-13.06-10.88-8.7-6.53-4.35-2.18-0
Anixa Biosciences P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.841.672.513.354.185.025.86
No extra charts and metrics for this ticker.